TechCrunch

FEBRUARY 25, 2023

No startup sector was entirely immune from 2022’s market uncertainty — except maybe AI — but some proved more resilient than others. Biotech was one of the most fortunate. Those figures fell short of the 1,415 biotech deals struck in 2021 worth a total of $39 billion. The sector recorded 1,054 U.S.-based

Biotech 237

Biotech Fintech Enterprise Performance 237

TechCrunch

APRIL 6, 2022

But the path won’t be easy: Many biotech companies working with psychedelic compounds must complete multiyear clinical trials that can cost over $100 million before winning FDA approval, similar to any other biotech company. The most important factor that can make or break a psychedelic biotech company is its team.

Biotech 246

Biotech Company Pharmaceuticals Healthcare 246

Crunchbase News

DECEMBER 9, 2024

tech unicorns made it to market. Biotech offerings, while more plentiful, are also running well below prior highs. Below, we pick out winners and losers for venture-backed tech and biotech companies, focusing on large- and medium-sized IPOs. footnote]since the companys March IPO , delivering a market cap around $26 billion.

Biotech 123

Biotech Film Performance Marketing 123

Crunchbase News

FEBRUARY 18, 2025

Marketing and personalization startup Hightouch locked up an $80 million Series C led by Sapphire Ventures , minting it as a new unicorn at a $1.2 Hightouchs AI Decisioning product allows marketers to synchronize data and then let AI agents decide what messages and/or experiences to send each customer personalizing the marketing effort.

Marketing 119

Marketing Artificial Inteligence Artificial Intelligence Biotech 119

Crunchbase News

JANUARY 6, 2025

Although 2024 was another exceptionally lackluster year for new public offerings, the IPO market could gain momentum in 2025 after its three-year lull. With that in mind, here are 13 companies that the Crunchbase News team thinks could be top contenders to go public if our 2025 market forecast bears out. That made sense.

Marketing 129

Marketing Company Technical Review Fintech 129

TechCrunch

FEBRUARY 28, 2022

Stämm Biotech , founded in 2014, is developing a desktop-sized bioreactor that looks pretty different from the tanks, tubes and knobs traditionally seen in industrial or even benchtop bioreactors. Image Credits: Stämm Biotech. And, as of writing, Ginkgo’s market cap was closer to $7.24 Image Credits: Stämm Biotech.

Biotech 226

Biotech 3D Chemicals Industry 226

TechCrunch

DECEMBER 16, 2022

“While it may feel counterintuitive, given the recent market environment, the value of the equity for all parties — investors, founders and employees — is higher in the more conservative growth scenario,” says Mitchem. 6 investors discuss why AI is more than just a buzzword in biotech. Target audience/market size slide.

Case Study 215

Case Study Biotech Survey Study 215

TechCrunch

MARCH 5, 2021

Just some of the core competencies you need to lock down include how to raise VC funding, recruiting the right people, finding product-market fit and building a killer go-to-market team. Founders in the earliest stages of startup life face a hefty learning curve. The list goes on and on…and on.

Biotech 244

Biotech Recruiting How To Marketing 244

TechCrunch

MARCH 21, 2023

When you think of life sciences and biotech hubs in the U.S., Portal Innovations , a biotech VC firm based in Chicago, is trying to broaden everyone’s horizons and give opportunities to biotech startups growing out of labs in Chicago, Atlanta, and hopefully beyond. As AI pervades biotech, what are investors looking for in 2023?

Biotech 203

Biotech Development Team Review Technical Review Innovation 203

N2Growth Blog

OCTOBER 23, 2023

Additionally, the industry’s highly regulated nature means that executives must have a keen eye for compliance and a strong ability to navigate the ever-changing market dynamics. Top executive search firms also bring a unique set of resources and expertise to the table when it comes to attracting top talent for biotech companies.

Biotech 178

Biotech Strategy Artificial Inteligence Recruiting 178

TechCrunch

APRIL 8, 2022

. “Gogoro will use the fresh funds from its IPO to continue to expand in Taiwan as it branches outward to larger markets like China, India and Indonesia,” writes transportation reporter Rebecca Bellan. 6 questions investors should ask when evaluating psychedelic biotech companies. Image Credits: Bryce Durbin/TechCrunch.

Biotech 222

Biotech Windows Transportation Travel 222

CIO

MARCH 4, 2025

From lab to market at lightning speed Not long ago, cutting-edge research might take decades to translate into real-world products. The path from lab to market keeps shortening. Many Fortune 500 companies now invest in AI, robotics and biotech startups through corporate venture arms, gaining insights and strategic advantage.

Technology 177

Technology Biotech Artificial Inteligence Artificial Intelligence 177

TechCrunch

AUGUST 18, 2022

Analysts estimate that the market for “delaying human death” could be worth $610 billion by 2025. In his view, the total addressable market of longevity-related plays is both smaller and potentially much larger than that. According to JME Ventures partner Samuel Gil, the opportunities in longevity are “endless.”

Biotech 313

Biotech Survey Groups Healthcare 313

TechCrunch

JUNE 24, 2022

Helping a small company find its momentum and grow to capture market share while making money has the ring of a great job description. 3 tips for biotech startups seeking non-dilutive capital to weather the downturn. Even if their tech is world-changing, it will still be years before it comes to market.

Biotech 210

Biotech Windows Real Estate Company 210

Crunchbase News

FEBRUARY 19, 2025

Even so, investment remains below the heights scaled during the 2021 market peak. Its stock has performed well, with shares up several-fold and a recent market cap around $11 billion. Funding at the intersection of healthcare and AI has been on a tear this past year. Last year, more than $7.5

Healthcare 115

Healthcare Artificial Inteligence Biotech Artificial Intelligence 115

Crunchbase News

MAY 24, 2024

This year is shaping up as the first we’ve seen in which biotech and healthcare startups receive a majority of U.S. So far in 2024, biotech and health companies have pulled in around $5.6 The biotech sector’s comparatively strong showing comes as overall Series A dealmaking looks on track to come in a bit above last year’s totals.

Biotech 137

Biotech Healthcare Generative AI Analysis 137

TechCrunch

JUNE 30, 2021

The American IPO market is hot for many companies, but surprisingly cool for others. The Exchange explores startups, markets and money. We’re talking tech companies here, I should add; The Exchange doesn’t track IPO results for commodities diggers and biotech labs. It’s a big world. We have to focus.

Marketing 230

Marketing Biotech .Net Company 230

Crunchbase News

JANUARY 10, 2025

By Caleb Appleton Having invested in the biotech space since before it had a name, Ive seen life sciences investors steer founders toward a therapeutics pipeline in hopes of securing the payout of a winning drug or medical device. Does the market see value in the tool today, or do you need to educate? What is your superpower?

Biotech 115

Biotech Marketing Hardware Industry 115

Crunchbase News

MARCH 3, 2025

lead portfolio companies for this group to go public biotechs Camp4 Therapeutics and BioAge Labs have fared poorly since their fall debuts. This includes grocery delivery service Instacart , marketing automation platform Klaviyo , and data security provider Rubrik. Meanwhile, the last U.S.

Biotech 116

Biotech Marketing Company Data 116

TechCrunch

APRIL 6, 2022

Navigating the choppy e-commerce seas : As reporter Ingrid Lunden writes, “e-commerce is synonymous with shopping on Amazon, but the reality is that a retailer has the option to use a bundle of different channels to sell and market products.” 6 questions investors should ask when evaluating psychedelic biotech companies. Big Tech Inc.

Marketing 235

Marketing Biotech Retail 3D 235

TechCrunch

MAY 31, 2022

The appetite for genomic data continues to rise in the field of biotech and pharmaceutical research, but cost is still a factor — even sequencing a full genome now costs as little as $1,000. This could push the price lower, but for now a 90% reduction is more than enough to go to market with.

Biotech 315

Biotech Pharmaceuticals Study Artificial Inteligence 315

TechCrunch

JULY 26, 2021

The whole human proteome may be free to browse thanks to DeepMind , but at the bleeding edge of biotech new proteins are made and tested every day, a complex and time-consuming process. If everything works as advertised, Glyphic could be the new standard in protein sequencing just as demand skyrockets in the biotech world.

Biotech 249

Biotech Off-The-Shelf Chemicals Hardware 249

TechCrunch

MAY 4, 2022

.” A more favorable regulatory and social landscape is helping psychedelic startups gain a foothold, but they still have to walk a tightrope that’s susceptible to the vagaries of market sentiment. But as public market sentiment fluctuates, specialized VCs seem more likely to stick around for the whole trip. Ready for the trip?

Marketing 235

Marketing Technical Review Biotech Weak Development Team 235

TechCrunch

OCTOBER 28, 2022

Reporter Dominic-Madori Davis moderated a discussion with Yin, Mike Asem (founding partner of M25), and Accel partner Rich Wong that elicited suggestions for early-stage founders who don’t live in the 415 area code and spilled the tea about “the emerging markets on their radars.”. 5 tips for launching in a crowded web3 gaming market.

Technical Review 228

Technical Review Software Review Development Team Review TDD 228

TechCrunch

AUGUST 3, 2021

In 2020, 71 biotech companies went public. On July 30 alone, eight biotech companies were expected to begin trading, including Rani Therapeutics. . This is a hot and unique market for life science direction and we’re excited to be driving innovation in this area,” Imran tells TechCrunch. . So that’s quite important as well.” .

Biotech 245

Biotech Study .Net Systems Review 245

TechCrunch

DECEMBER 2, 2020

Sifting through the trillions of molecules out there that might have powerful medicinal effects is a daunting task, but the solution biotech has found is to work smarter, not harder. We will be hiring more top notch AI researchers, software engineers, medicinal chemists and biotech talent, as well as building our own research labs.”

Biotech 265

Biotech 3D Artificial Inteligence Machine Learning 265

Crunchbase News

JANUARY 7, 2025

funding market raised a greater proportion of global funding, up from 48% in 2023. Large early-stage rounds went to data centers, renewable energy, AI, robotics and biotech. An opening up of the IPO markets in 2025 will drive LP allocation to venture, said Beezer Clarkson , a partner at Sapphire Ventures , in an interview.

Artificial Inteligence 144

Artificial Inteligence Artificial Intelligence Report Technical Review 144

TechCrunch

OCTOBER 28, 2022

The biotech didn’t specify what roles and departments got trimmed. The Washington- and Lagos-based genomics startup has been considered the showpiece of Africa’s fledging biotech space since it got into Y Combinator in 2019. Yet, 2022 will be a year to forget for the biotech startup.

Biotech 229

Biotech Part-Time VPE Fractional VPE Pharmaceuticals 229

Crunchbase News

SEPTEMBER 20, 2024

Of course, biotech and fintech were in there too. tied) Serán Bioscience , $200M, biotech : The big biotech raise this week went to Serán Bioscience. A rather odd week in venture, as the biggest rounds were raised by greentech, business travel and charity startups. The new valuation represents a 62% jump from its previous $1.3

Biotech 116

Biotech Travel Fintech Pharmaceuticals 116

TechCrunch

JUNE 6, 2022

“Right now the market is in ‘biotechnology winter’ where many companies are running out of cash and are dying. This presents an opportunity for Insilico Medicine to emerge as a winner during the biotech spring.” Insilico has its own Chinese partner — pharmaceutical behemoth Fosun Pharma.

Biotech 211

Biotech Artificial Inteligence Artificial Intelligence Pharmaceuticals 211

TechCrunch

AUGUST 9, 2022

TechCrunch spends time each quarter covering the startup markets of the world. The Exchange explores startups, markets and money. The North American market is perhaps the most active startup region in the world. Is the Boston area’s software-and-biotech focus doing better than, say, the Bay Area’s startup machine?

Biotech 252

Biotech Data Marketing Examples 252

TechCrunch

FEBRUARY 28, 2023

Thanks very much for reading, Walter Thompson Editorial Manager, TechCrunch+ @yourprotagonist Using predictive LTV to juice up marketing campaigns Going private: A guide to PE tech acquisitions Image Credits: PM Images (opens in a new window) / Getty Images For private equity firms in search of bargains, now is a great time to be alive. .”

Biotech 212

Biotech Survey Generative AI Windows 212

TechCrunch

MARCH 15, 2021

A new nanocoating from Curran Biotech could dramatically improve air filtration to prevent the spread of COVID-19 indoors. We’ll cover every aspect of company building: Fundraising, recruiting, sales, product-market fit, PR, marketing and brand building. Use code “TCARTICLE at checkout to get 20% off tickets right here.

Biotech 257

Biotech Energy Recruiting Travel 257

TechCrunch

JANUARY 10, 2023

German-based biotech company BioNTech — one of the big manufacturers of COVID-19 vaccines, among other things — is set to acquire InstaDeep , a Tunis-born and U.K.-based It gives brands a way to conduct market research and collect first-party data, which is important as marketers prepare for a post-cookie world. Ivan has more.

Trends 219

Trends Marketing ChatGPT Windows 219

TechCrunch

MARCH 17, 2023

Zero-based budgeting: A proven framework for extending runway 5 strategies for biotech startups to outlast a market downturn Image Credits: Getty Images Spinning up a biotech company is a massive undertaking.

Budget 230

Budget Biotech Artificial Inteligence Banking 230

TechCrunch

MAY 26, 2021

So a new crop of biotech companies have worked to integrate these aspects. The money will go toward the requisite testing and paperwork involved in bringing a new drug to market based on promising leads. 2021 should be a banner year for biotech startups that make smart choices early.

Engineering 248

Engineering Biotech Chemicals Artificial Inteligence 248

Crunchbase News

DECEMBER 5, 2024

The IT infrastructure company said it will use the fresh cash for M&A activities and entering new markets globally. Insider , $500M, digital marketing: Marketing tech platform Insider raised a $500 million Series E led by General Atlantic to fund its expansion in the U.S. and AI product development. billion in 2021.

Artificial Inteligence 127

Artificial Inteligence Artificial Intelligence Generative AI Biotech 127